ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Singapore pushes 'one hour' coronavirus antibody tests for export

New kit raises hopes for gauging extent of immunity worldwide

The cPass test kit checks whether an individual has developed antibodies to fight the coronavirus.   © Duke-NUS Medical School, Singapore's Agency for Science, Technology and Research, GenScript Biotech

SINGAPORE -- Rapid test kits unveiled in Singapore on Friday promise to help governments worldwide assess the true spread of the coronavirus and the extent of public immunity.

The kits, called cPass, were developed after trials on COVID-19 patients in China and the city-state. They signal whether a subject has developed antibodies, or a biological response to fight the disease. This would mean they were infected at some point.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more